Unichem Laboratories Share Price
468.95+0.00 (-2.15%)
+0.55% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
UNICHEMLABNSE
Unichem Laboratories Share Price
468.95+0.00 (-2.15%)
+0.55% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 5% | 12% | 18% | 4% |
| 9% | 49% | - | 84% |
| 6% | 18% | 4% | 1% |
| -1% | 1% | 4% | 10% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
LAURUSLABS
ZYDUSLIFE
DRREDDY
CIPLA
MANKIND
AUROPHARMA
LUPIN
UNICHEMLAB
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,908.7 | ₹456593 Cr | 41.64 | 8.29 | 58.23 | ₹11479 Cr |
| 11,120.5 | ₹296741 Cr | 88.24 | 42.53 | 146.01 | ₹2568 Cr |
| 4,626.2 | ₹175578 Cr | 82.66 | 14.04 | 106.21 | ₹2163 Cr |
| 2,304.4 | ₹124380 Cr | 92.83 | 8.17 | 33.94 | ₹889 Cr |
| 1,235 | ₹119700 Cr | 28.64 | 9.27 | 62.23 | ₹5040 Cr |
| 1,396.5 | ₹116771 Cr | 41.71 | 11.08 | 59.16 | ₹4196 Cr |
| 1,421.8 | ₹114397 Cr | 39.49 | 10.86 | 52.6 | ₹3879 Cr |
| 2,636.7 | ₹108641 Cr | 48.44 | 17.23 | 76.25 | ₹1913 Cr |
| 1,803.3 | ₹103971 Cr | 26.06 | 19.57 | 103.44 | ₹3505 Cr |
| 2,002.6 | ₹91413 Cr | 17.56 | 25.26 | 150.99 | ₹5333 Cr |
| 474.2 | ₹3380 Cr | 9.97 | 3.16 | 65.5 | ₹253 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Sep 2018 | Jun 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹640 Cr | ₹633 Cr | ₹575 Cr | ₹521 Cr | ₹579 Cr | ₹527 Cr | ₹587 Cr | ₹533 Cr | ₹507 Cr | ₹483 Cr | ₹460 Cr | ₹466 Cr | ₹416 Cr | ₹423 Cr | ₹402 Cr | ₹302 Cr | ₹329 Cr | ₹310 Cr | ₹370 Cr | ₹311 Cr | ₹291 Cr | ₹298 Cr | ₹274 Cr | ₹326 Cr | ₹318 Cr | ₹317 Cr | ₹290 Cr | ₹275 Cr | ₹268 Cr | ₹273 Cr | ₹374 Cr | ₹261 Cr | ₹241 Cr |
| ₹15 Cr | ₹16 Cr | ₹23 Cr | ₹12 Cr | ₹21 Cr | ₹7 Cr | ₹9 Cr | ₹14 Cr | ₹9 Cr | ₹4 Cr | ₹6 Cr | ₹11 Cr | ₹6 Cr | ₹9 Cr | ₹5 Cr | ₹16 Cr | ₹9 Cr | ₹8 Cr | ₹14 Cr | ₹15 Cr | ₹3 Cr | ₹16 Cr | ₹8 Cr | ₹16 Cr | ₹10 Cr | ₹17 Cr | ₹12 Cr | ₹25 Cr | ₹28 Cr | ₹26 Cr | ₹21 Cr | ₹32 Cr | ₹19 Cr |
| ₹656 Cr | ₹648 Cr | ₹599 Cr | ₹533 Cr | ₹600 Cr | ₹533 Cr | ₹596 Cr | ₹547 Cr | ₹516 Cr | ₹487 Cr | ₹466 Cr | ₹477 Cr | ₹421 Cr | ₹432 Cr | ₹407 Cr | ₹319 Cr | ₹338 Cr | ₹317 Cr | ₹384 Cr | ₹326 Cr | ₹293 Cr | ₹314 Cr | ₹282 Cr | ₹342 Cr | ₹328 Cr | ₹334 Cr | ₹302 Cr | ₹300 Cr | ₹296 Cr | ₹299 Cr | ₹395 Cr | ₹293 Cr | ₹260 Cr |
| ₹596 Cr | ₹593 Cr | ₹558 Cr | ₹508 Cr | ₹544 Cr | ₹536 Cr | ₹533 Cr | ₹478 Cr | ₹484 Cr | ₹475 Cr | ₹469 Cr | ₹466 Cr | ₹436 Cr | ₹424 Cr | ₹415 Cr | ₹376 Cr | ₹376 Cr | ₹335 Cr | ₹325 Cr | ₹335 Cr | ₹306 Cr | ₹322 Cr | ₹277 Cr | ₹317 Cr | ₹309 Cr | ₹326 Cr | ₹300 Cr | ₹311 Cr | ₹316 Cr | ₹312 Cr | ₹369 Cr | ₹331 Cr | ₹290 Cr |
| ₹90 Cr | ₹86 Cr | ₹71 Cr | ₹57 Cr | ₹87 Cr | ₹29 Cr | ₹93 Cr | ₹99 Cr | ₹64 Cr | ₹44 Cr | ₹28 Cr | ₹42 Cr | ₹14 Cr | ₹37 Cr | ₹22 Cr | -₹26 Cr | -₹9 Cr | ₹7 Cr | ₹83 Cr | ₹14 Cr | ₹9 Cr | ₹14 Cr | ₹27 Cr | ₹46 Cr | ₹40 Cr | ₹29 Cr | ₹25 Cr | ₹8 Cr | ₹1 Cr | ₹6 Cr | ₹44 Cr | -₹22 Cr | -₹16 Cr |
| ₹8 Cr | ₹7 Cr | ₹9 Cr | ₹7 Cr | ₹8 Cr | ₹7 Cr | ₹5 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹4 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹79 L | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr |
| ₹27 Cr | ₹49 Cr | ₹19 Cr | ₹293 Cr | -₹11 Cr | -₹9 Cr | ₹58 Cr | ₹62 Cr | ₹27 Cr | ₹8 Cr | -₹133 Cr | ₹73 Cr | -₹22 Cr | ₹2 Cr | -₹47 Cr | -₹61 Cr | -₹47 Cr | -₹21 Cr | ₹58 Cr | -₹11 Cr | -₹15 Cr | -₹9 Cr | ₹3 Cr | ₹24 Cr | ₹18 Cr | ₹7 Cr | -₹17 L | -₹14 Cr | -₹22 Cr | -₹13 Cr | ₹23 Cr | -₹40 Cr | -₹31 Cr |
| ₹22 Cr | ₹41 Cr | ₹11 Cr | ₹264 Cr | -₹12 Cr | -₹10 Cr | ₹53 Cr | ₹58 Cr | ₹25 Cr | ₹2 Cr | -₹137 Cr | ₹73 Cr | -₹24 Cr | -₹67 L | -₹44 Cr | -₹64 Cr | -₹71 Cr | -₹23 Cr | ₹71 Cr | -₹13 Cr | -₹13 Cr | -₹11 Cr | -₹17 L | ₹24 Cr | ₹9 Cr | ₹2 Cr | -₹18 Cr | -₹15 Cr | -₹22 Cr | -₹6 Cr | ₹38 Cr | -₹40 Cr | -₹21 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
| ₹6 Cr | ₹5 Cr | ₹3 Cr | ₹12 Cr | ₹11 Cr | ₹8 Cr | ₹5 Cr | ₹4 Cr | ₹59 L | ₹1 Cr | ₹1 Cr | ₹85 L | ₹75 L | ₹100 L | ₹72 L | ₹81 L | ₹69 L | ₹2 Cr | ₹1 Cr |
| ₹2697 Cr | ₹2431 Cr | ₹2421 Cr | ₹2409 Cr | ₹2594 Cr | ₹2535 Cr | ₹2512 Cr | ₹2602 Cr | ₹2665 Cr | ₹1044 Cr | ₹935 Cr | ₹849 Cr | ₹798 Cr | ₹708 Cr | ₹642 Cr | ₹599 Cr | ₹544 Cr | ₹464 Cr | ₹392 Cr |
| ₹2697 Cr | ₹2431 Cr | ₹2421 Cr | ₹2409 Cr | ₹2594 Cr | ₹2535 Cr | ₹2512 Cr | ₹2602 Cr | ₹2665 Cr | ₹1044 Cr | ₹935 Cr | ₹849 Cr | ₹798 Cr | ₹708 Cr | ₹642 Cr | ₹599 Cr | ₹544 Cr | ₹464 Cr | ₹392 Cr |
| ₹2717 Cr | ₹2451 Cr | ₹2438 Cr | ₹2435 Cr | ₹2618 Cr | ₹2557 Cr | ₹2531 Cr | ₹2620 Cr | ₹2680 Cr | ₹1064 Cr | ₹954 Cr | ₹868 Cr | ₹817 Cr | ₹727 Cr | ₹661 Cr | ₹618 Cr | ₹563 Cr | ₹484 Cr | ₹412 Cr |
| ₹39 Cr | ₹61 Cr | ₹38 Cr | ₹64 Cr | ₹89 Cr | ₹0 | ₹0 | ₹0 | ₹33 L | ₹44 L | ₹23 Cr | ₹20 Cr | ₹25 Cr | ₹21 Cr | ₹20 Cr | ₹19 Cr | ₹15 Cr | ₹21 Cr | ₹6 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹23 Cr | ₹20 Cr | ₹19 Cr | ₹18 Cr |
| ₹9 Cr | -₹26 Cr | -₹7 Cr | -₹10 Cr | -₹4 Cr | -₹25 L | -₹3 Cr | -₹9 Cr | ₹31 Cr | ₹19 Cr | ₹21 Cr | ₹24 Cr | ₹42 Cr | ₹39 Cr | ₹38 Cr | ₹38 Cr | ₹35 Cr | ₹32 Cr | ₹32 Cr |
| ₹26 Cr | ₹26 Cr | ₹25 Cr | ₹13 Cr | ₹19 Cr | ₹19 Cr | ₹23 Cr | ₹5 Cr | ₹5 Cr | ₹20 Cr | ₹19 Cr | ₹21 Cr | ₹24 Cr | ₹25 Cr | ₹23 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹29 Cr | ₹38 Cr | ₹36 Cr | ₹42 Cr | ₹40 Cr | ₹30 Cr | ₹24 Cr | ₹15 Cr | ₹11 Cr | ₹25 Cr | ₹13 Cr | ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹10 Cr | ₹8 Cr | ₹0 | ₹0 | ₹0 |
| ₹104 Cr | ₹99 Cr | ₹92 Cr | ₹108 Cr | ₹144 Cr | ₹49 Cr | ₹44 Cr | ₹10 Cr | ₹46 Cr | ₹64 Cr | ₹76 Cr | ₹74 Cr | ₹98 Cr | ₹94 Cr | ₹93 Cr | ₹87 Cr | ₹70 Cr | ₹72 Cr | ₹57 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹357 Cr | ₹387 Cr | ₹351 Cr | ₹291 Cr | ₹183 Cr | ₹210 Cr | ₹250 Cr | ₹221 Cr | ₹226 Cr | ₹211 Cr | ₹164 Cr | ₹138 Cr | ₹151 Cr | ₹157 Cr | ₹140 Cr | ₹110 Cr | ₹115 Cr | ₹101 Cr | ₹90 Cr |
| ₹109 Cr | ₹123 Cr | ₹93 Cr | ₹128 Cr | ₹135 Cr | ₹177 Cr | ₹122 Cr | ₹68 Cr | ₹63 Cr | ₹68 Cr | ₹61 Cr | ₹46 Cr | ₹33 Cr | ₹37 Cr | ₹34 Cr | ₹26 Cr | ₹15 Cr | ₹16 Cr | ₹11 Cr |
| ₹415 Cr | ₹340 Cr | ₹155 Cr | ₹208 Cr | ₹216 Cr | ₹101 Cr | ₹184 Cr | ₹200 Cr | ₹150 Cr | ₹98 Cr | ₹13 Cr | ₹2 Cr | ₹1 Cr | ₹6 Cr | ₹25 Cr | ₹9 Cr | ₹0 | ₹0 | ₹0 |
| ₹5 Cr | ₹142 Cr | ₹138 Cr | ₹12 Cr | ₹18 Cr | ₹18 Cr | ₹10 Cr | ₹13 Cr | ₹24 Cr | ₹16 Cr | ₹38 Cr | ₹26 Cr | ₹46 Cr | ₹52 Cr | ₹33 Cr | ₹31 Cr | ₹36 Cr | ₹29 Cr | ₹34 Cr |
| ₹886 Cr | ₹992 Cr | ₹738 Cr | ₹640 Cr | ₹552 Cr | ₹506 Cr | ₹567 Cr | ₹503 Cr | ₹464 Cr | ₹393 Cr | ₹275 Cr | ₹212 Cr | ₹230 Cr | ₹251 Cr | ₹233 Cr | ₹176 Cr | ₹165 Cr | ₹146 Cr | ₹135 Cr |
| ₹3707 Cr | ₹3544 Cr | ₹3268 Cr | ₹3183 Cr | ₹3314 Cr | ₹3112 Cr | ₹3142 Cr | ₹3133 Cr | ₹3190 Cr | ₹1521 Cr | ₹1305 Cr | ₹1153 Cr | ₹1145 Cr | ₹1073 Cr | ₹987 Cr | ₹881 Cr | ₹799 Cr | ₹703 Cr | ₹603 Cr |
| ₹126 Cr | ₹121 Cr | ₹32 Cr | ₹151 Cr | ₹145 Cr | ₹152 Cr | ₹182 Cr | ₹152 Cr | ₹24 Cr | ₹38 Cr | ₹48 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹469 Cr | ₹430 Cr | ₹219 Cr | ₹297 Cr | ₹330 Cr | ₹101 Cr | ₹184 Cr | ₹200 Cr | ₹151 Cr | ₹98 Cr | ₹36 Cr | ₹22 Cr | ₹26 Cr | ₹27 Cr | ₹46 Cr | ₹51 Cr | ₹36 Cr | ₹40 Cr | ₹24 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹1992 Cr | ₹1994 Cr | ₹1920 Cr | ₹1750 Cr | ₹1380 Cr | ₹1194 Cr | ₹1098 Cr | ₹976 Cr | ₹690 Cr | ₹561 Cr | ₹440 Cr | ₹725 Cr | ₹688 Cr | ₹676 Cr | ₹599 Cr | ₹537 Cr | ₹465 Cr | ₹414 Cr | ₹333 Cr |
| ₹779 Cr | ₹694 Cr | ₹667 Cr | ₹494 Cr | ₹390 Cr | ₹313 Cr | ₹232 Cr | ₹170 Cr | ₹115 Cr | ₹74 Cr | ₹37 Cr | ₹309 Cr | ₹269 Cr | ₹228 Cr | ₹191 Cr | ₹160 Cr | ₹131 Cr | ₹113 Cr | ₹95 Cr |
| ₹1213 Cr | ₹1300 Cr | ₹1252 Cr | ₹1257 Cr | ₹990 Cr | ₹880 Cr | ₹866 Cr | ₹806 Cr | ₹574 Cr | ₹487 Cr | ₹403 Cr | ₹416 Cr | ₹419 Cr | ₹448 Cr | ₹408 Cr | ₹377 Cr | ₹333 Cr | ₹301 Cr | ₹238 Cr |
| ₹100 Cr | ₹31 Cr | ₹123 Cr | ₹147 Cr | ₹494 Cr | ₹567 Cr | ₹330 Cr | ₹92 Cr | ₹238 Cr | ₹250 Cr | ₹237 Cr | ₹123 Cr | ₹91 Cr | ₹132 Cr | ₹113 Cr | ₹63 Cr | ₹63 Cr | ₹76 Cr | ₹103 Cr |
| ₹2 L | ₹2 L | ₹2 L | ₹16 L | ₹28 L | ₹156 Cr | ₹131 Cr | ₹126 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹3 L | ₹3 L | ₹3 L | ₹2 L | ₹8 L |
| ₹2 L | ₹2 L | ₹2 L | ₹16 L | ₹28 L | ₹156 Cr | ₹131 Cr | ₹126 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹3 L | ₹3 L | ₹3 L | ₹2 L | ₹8 L |
| ₹194 Cr | ₹151 Cr | ₹125 Cr | ₹168 Cr | ₹166 Cr | ₹113 Cr | ₹113 Cr | ₹56 Cr | ₹24 Cr | ₹20 Cr | ₹28 Cr | ₹45 Cr | ₹48 Cr | ₹8 Cr | ₹26 Cr | ₹16 Cr | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹25 Cr | ₹21 Cr | ₹19 Cr | ₹16 Cr | ₹15 Cr | ₹12 Cr | ₹9 Cr | ₹8 Cr | ₹5 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹1506 Cr | ₹1506 Cr | ₹1522 Cr | ₹1591 Cr | ₹1666 Cr | ₹1734 Cr | ₹1455 Cr | ₹1094 Cr | ₹854 Cr | ₹772 Cr | ₹673 Cr | ₹589 Cr | ₹564 Cr | ₹594 Cr | ₹547 Cr | ₹457 Cr | ₹396 Cr | ₹377 Cr | ₹341 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹0 | ₹0 | ₹1 Cr | ₹2 Cr | ₹264 Cr | ₹236 Cr | ₹419 Cr | ₹801 Cr | ₹896 Cr | ₹8 Cr | ₹8 Cr | ₹35 Cr | ₹6 Cr | ₹33 Cr | ₹15 Cr | ₹21 Cr | ₹59 Cr | ₹1 Cr | ₹0 |
| ₹975 Cr | ₹989 Cr | ₹736 Cr | ₹625 Cr | ₹600 Cr | ₹538 Cr | ₹397 Cr | ₹339 Cr | ₹273 Cr | ₹282 Cr | ₹231 Cr | ₹208 Cr | ₹203 Cr | ₹143 Cr | ₹158 Cr | ₹150 Cr | ₹108 Cr | ₹103 Cr | ₹83 Cr |
| ₹829 Cr | ₹779 Cr | ₹642 Cr | ₹589 Cr | ₹495 Cr | ₹250 Cr | ₹390 Cr | ₹436 Cr | ₹277 Cr | ₹315 Cr | ₹220 Cr | ₹192 Cr | ₹197 Cr | ₹207 Cr | ₹183 Cr | ₹185 Cr | ₹167 Cr | ₹152 Cr | ₹140 Cr |
| ₹295 Cr | ₹118 Cr | ₹158 Cr | ₹185 Cr | ₹114 Cr | ₹82 Cr | ₹234 Cr | ₹201 Cr | ₹681 Cr | ₹16 Cr | ₹20 Cr | ₹27 Cr | ₹52 Cr | ₹25 Cr | ₹23 Cr | ₹15 Cr | ₹24 Cr | ₹34 Cr | ₹10 Cr |
| ₹33 Cr | ₹43 Cr | ₹30 Cr | ₹31 Cr | ₹33 Cr | ₹56 Cr | ₹58 Cr | ₹61 Cr | ₹61 Cr | ₹27 Cr | ₹31 Cr | ₹21 Cr | ₹17 Cr | ₹9 Cr | ₹7 Cr | ₹6 Cr | ₹0 | ₹0 | ₹0 |
| ₹66 Cr | ₹102 Cr | ₹175 Cr | ₹156 Cr | ₹138 Cr | ₹214 Cr | ₹189 Cr | ₹201 Cr | ₹149 Cr | ₹101 Cr | ₹123 Cr | ₹82 Cr | ₹106 Cr | ₹62 Cr | ₹53 Cr | ₹47 Cr | ₹45 Cr | ₹36 Cr | ₹28 Cr |
| ₹2197 Cr | ₹2029 Cr | ₹1743 Cr | ₹1588 Cr | ₹1645 Cr | ₹1377 Cr | ₹1686 Cr | ₹2038 Cr | ₹2336 Cr | ₹748 Cr | ₹632 Cr | ₹564 Cr | ₹581 Cr | ₹478 Cr | ₹439 Cr | ₹425 Cr | ₹402 Cr | ₹326 Cr | ₹261 Cr |
| ₹1311 Cr | ₹1038 Cr | ₹1006 Cr | ₹949 Cr | ₹1093 Cr | ₹872 Cr | ₹1120 Cr | ₹1536 Cr | ₹1873 Cr | ₹356 Cr | ₹357 Cr | ₹353 Cr | ₹350 Cr | ₹227 Cr | ₹206 Cr | ₹249 Cr | ₹237 Cr | ₹180 Cr | ₹127 Cr |
| ₹3707 Cr | ₹3544 Cr | ₹3268 Cr | ₹3183 Cr | ₹3314 Cr | ₹3112 Cr | ₹3142 Cr | ₹3133 Cr | ₹3190 Cr | ₹1521 Cr | ₹1305 Cr | ₹1153 Cr | ₹1145 Cr | ₹1073 Cr | ₹987 Cr | ₹881 Cr | ₹799 Cr | ₹703 Cr | ₹603 Cr |
| ₹385 | ₹347 | ₹346 | ₹344 | ₹370 | ₹362 | ₹359 | ₹372 | ₹381 | ₹117 | ₹105 | ₹95 | ₹90 | ₹80 | ₹73 | ₹68 | ₹156 | ₹134 | ₹114 |
| ₹385 | ₹347 | ₹346 | ₹344 | ₹370 | ₹362 | ₹359 | ₹372 | ₹381 | ₹117 | ₹105 | ₹95 | ₹90 | ₹80 | ₹73 | ₹68 | ₹62 | ₹54 | ₹46 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹292 Cr | ₹155 Cr | -₹85 Cr | -₹176 Cr | ₹22 Cr | ₹51 Cr | -₹48 Cr | -₹57 Cr | ₹3241 Cr | ₹141 Cr | ₹137 Cr | ₹77 Cr | ₹171 Cr | ₹146 Cr | ₹94 Cr | ₹127 Cr | ₹153 Cr | ₹127 Cr | ₹68 Cr |
| -₹73 Cr | ₹149 Cr | ₹197 Cr | ₹133 Cr | ₹80 Cr | ₹66 Cr | ₹19 Cr | ₹7 Cr | -₹3208 Cr | ₹53 Cr | ₹41 Cr | ₹36 Cr | ₹19 Cr | ₹47 Cr | ₹39 Cr | ₹28 Cr | ₹25 Cr | ₹25 Cr | ₹24 Cr |
| -₹208 Cr | -₹294 Cr | -₹92 Cr | -₹29 Cr | -₹354 Cr | -₹70 Cr | ₹54 Cr | -₹265 Cr | -₹147 Cr | -₹99 Cr | -₹36 Cr | -₹16 Cr | -₹66 Cr | ₹13 Cr | ₹14 Cr | -₹55 Cr | -₹22 Cr | -₹30 Cr | -₹11 Cr |
| ₹11 Cr | ₹9 Cr | ₹20 Cr | -₹73 Cr | -₹252 Cr | ₹47 Cr | ₹24 Cr | -₹316 Cr | -₹113 Cr | ₹96 Cr | ₹143 Cr | ₹96 Cr | ₹124 Cr | ₹206 Cr | ₹147 Cr | ₹99 Cr | ₹157 Cr | ₹123 Cr | ₹81 Cr |
| ₹4 Cr | -₹7 Cr | ₹14 Cr | -₹85 Cr | -₹260 Cr | ₹33 Cr | ₹20 Cr | -₹328 Cr | -₹112 Cr | ₹68 Cr | ₹112 Cr | ₹78 Cr | ₹87 Cr | ₹171 Cr | ₹124 Cr | ₹69 Cr | ₹129 Cr | ₹103 Cr | ₹70 Cr |
| ₹192 Cr | -₹241 Cr | ₹50 Cr | ₹203 Cr | ₹102 Cr | -₹74 Cr | -₹36 Cr | -₹286 Cr | ₹1648 Cr | -₹128 Cr | -₹85 Cr | -₹52 Cr | ₹36 Cr | -₹118 Cr | -₹102 Cr | -₹48 Cr | -₹100 Cr | -₹58 Cr | -₹82 Cr |
| ₹2 Cr | ₹184 Cr | -₹106 Cr | -₹81 Cr | ₹191 Cr | -₹121 Cr | -₹62 Cr | -₹2 Cr | -₹881 Cr | ₹59 Cr | -₹33 Cr | -₹51 Cr | -₹95 Cr | -₹51 Cr | -₹14 Cr | -₹29 Cr | -₹40 Cr | -₹21 Cr | -₹5 Cr |
| ₹198 Cr | -₹64 Cr | -₹42 Cr | ₹36 Cr | ₹34 Cr | -₹162 Cr | -₹78 Cr | -₹616 Cr | ₹655 Cr | -₹46 L | -₹7 Cr | -₹25 Cr | ₹28 Cr | ₹1 Cr | ₹8 Cr | -₹8 Cr | -₹11 Cr | ₹24 Cr | -₹17 Cr |
| ₹90 Cr | ₹155 Cr | ₹184 Cr | ₹109 Cr | ₹77 Cr | ₹232 Cr | ₹197 Cr | ₹666 Cr | ₹11 Cr | ₹12 Cr | ₹27 Cr | ₹52 Cr | ₹25 Cr | ₹23 Cr | ₹15 Cr | ₹24 Cr | ₹34 Cr | ₹10 Cr | ₹27 Cr |
| ₹2 Cr | -₹68 L | ₹13 Cr | ₹38 Cr | -₹2 Cr | ₹8 Cr | ₹113 Cr | ₹147 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹289 Cr | ₹90 Cr | ₹155 Cr | ₹184 Cr | ₹109 Cr | ₹77 Cr | ₹232 Cr | ₹197 Cr | ₹666 Cr | ₹11 Cr | ₹20 Cr | ₹27 Cr | ₹52 Cr | ₹25 Cr | ₹23 Cr | ₹15 Cr | ₹24 Cr | ₹34 Cr | ₹10 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Unichem Laboratories Share Price
468.95+0.00 (-2.15%)
+0.55% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 6 out of 9 oscillators
RSI
34.77Sell
STOCH %K
5.12Buy
MACD Level(12,26)
-9.75Sell
Ultimate Oscillator
31.82Sell
Aroon Oscillator
-34.00Sell
BOP
-0.29Sell
CCI
-139.34Buy
Williams %R
-94.88Buy
Momentum
-34.90Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 1
Bearish signals: 8 out of 9 moving averages
EMA 9
484.98Sell
SMA 9
489.63Sell
EMA 21
494.38Sell
SMA 21
491.58Sell
EMA 50
506.66Sell
SMA 50
515.97Sell
EMA 200
488.00Sell
SMA 200
447.30Buy
WMA 20
491.07Sell
Pivot
Pivot
Classic
Resistance 5
522.55
Resistance 4
511.75
Resistance 3
500.95
Resistance 2
490.15
Resistance 1
484.70
Pivot
479.35
Support 1
473.90
Support 2
468.55
Support 3
457.75
Support 4
446.95
Support 5
436.15
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Unichem Laboratories Share Price
468.95+0.00 (-2.15%)
+0.55% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% |
| 2.70% | 0.90% | 1.00% | 0.99% | 1.00% | 0.98% |
| 0.75% | 1.14% | 1.56% | 1.56% | 1.58% | 1.53% |
| 8.65% | 9.32% | 9.07% | 9.17% | 9.17% | 9.39% |
| 17.68% | 18.42% | 18.15% | 18.06% | 18.03% | 17.88% |
Bulk & block deals
Name
Polunin Emerging Markets Small Cap Fund Llc
Jump Trading Financial India Private Limited
Qe Securities Llp
Elixir Wealth Management Private Limited
Irage Broking Services Llp
Junomoneta Finsol Private Limited
Nk Securities Research Private Limited
Microcurves Trading Private Limited
Jump Trading Financial India Private Limited
Junomoneta Finsol Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 09 Jul 2026 | Purchase | 38.84 Cr | ₹646.44 | 6.01 L | Bulk | 0.853482 | NSE |
| 11 Jun 2026 | Purchase | 25.39 Cr | ₹490.22 | 5.18 L | Bulk | 0.735731 | NSE |
| 11 Jun 2026 | Purchase | 30.15 Cr | ₹490.39 | 6.15 L | Bulk | 0.873289 | NSE |
| 11 Jun 2026 | Purchase | 30.06 Cr | ₹488.36 | 6.16 L | Bulk | 0.874222 | NSE |
| 11 Jun 2026 | Purchase | 34.48 Cr | ₹485.58 | 7.10 L | Bulk | 1.00843 | NSE |
| 11 Jun 2026 | Purchase | 44.72 Cr | ₹487.89 | 9.17 L | Bulk | 1.301989 | NSE |
| 11 Jun 2026 | Purchase | 51.74 Cr | ₹486.70 | 10.63 L | Bulk | 1.509836 | NSE |
| 11 Jun 2026 | Purchase | 42.29 Cr | ₹489.27 | 8.64 L | Bulk | 1.227714 | NSE |
| 11 Jun 2026 | Sell | 25.39 Cr | ₹490.11 | 5.18 L | Bulk | 0.735731 | NSE |
| 11 Jun 2026 | Sell | 45.10 Cr | ₹488.31 | 9.24 L | Bulk | 1.311902 | NSE |
Insider trading & SAST
Client name
Equity Intelligence India Pvt Ltd
Equity Intelligence India Pvt Ltd
Jatin Ramanlal Mehta
Gerard Majella Cole
Rajaram Pai
Ipca Laboratories Ltd
Ipca Laboratories Limited
Hdfc Mutual Fund
Vandana Pandey
Dilip Kunkolienkar
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 Jul 2026 | Other | Disposal | 0.43 | 0.56 | 0 | — | 3 L | 11 Jun 2026 | Market | 3,94,375 | SAST | 29(2) | — |
| 14 Jul 2026 | Other | Disposal | 0.43 | 0.56 | 0 | — | 3 L | 11 Jun 2026 | Market | 3,94,375 | SAST | 29(2) | — |
| 10 Oct 2023 | Employee | Disposal | 0.018748 | 0 | 58.08 L | ₹440 | 13.20 K | 21 Sep 2023 | Others | 0 | Insider Trading | — | Equity Shares |
| 10 Oct 2023 | Designated Person | Disposal | 0.006599 | 0 | 20.44 L | ₹440 | 4.65 K | 21 Sep 2023 | Others | 0 | Insider Trading | — | Equity Shares |
| 10 Oct 2023 | Designated Person | Disposal | 0.005681 | 0 | 17.60 L | ₹440 | 4 K | 21 Sep 2023 | Others | 0 | Insider Trading | — | Equity Shares |
| 26 Sep 2023 | Promoter | Acquisition | 19.29 | 52.67 | 0 | — | 1.36 Cr | 21 Sep 2023 | Open Offer | 3,70,81,011 | SAST | 29(2) | — |
| 22 Sep 2023 | Promoter | Acquisition | 19.287574 | 52.67 | 598.33 Cr | ₹440.61 | 1.36 Cr | 21 Sep 2023 | Others | 3,70,81,011 | Insider Trading | — | Equity Shares |
| 11 Sep 2023 | Other | Acquisition | 2.07 | 7.41 | 0 | — | 14.56 L | 30 Aug 2023 | Market | 52,14,513 | SAST | 29(2) | — |
| 24 Aug 2023 | Employee | Disposal | 0.008522 | 0 | 24.40 L | ₹406.74 | 6 K | 22 Aug 2023 | Market Sale | 1,500 | Insider Trading | — | Equity Shares |
| 23 Aug 2023 | Director | Disposal | 0.007102 | 0 | 20.41 L | ₹408.22 | 5 K | 21 Aug 2023 - 22 Aug 2023 | Market Sale | 279 | Insider Trading | — | Equity Shares |
Unichem Laboratories Share Price
468.95+0.00 (-2.15%)
+0.55% past 1 Year
Unichem Laboratories Limited, incorporated in 1962, is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company has a strong footprint in the generic business for more than
Corporate Actions
Date
Type
Details
Company details
Unichem Laboratories Share Price
468.95+0.00 (-2.15%)
+0.55% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Unichem Laboratories Share Price
468.95+0.00 (-2.15%)
+0.55% past 1 Year
News
1 of 20
ResultUNICHEMLAB4 Nov 2026
NULL
Unichem Laboratories Reports Higher Second Quarter EBITDA And Margin
ResultUNICHEMLAB4 Nov 2026
Unichem Laboratories reported second-quarter EBITDA of Rs 74.40 crores, compared with Rs 66.10 crores in the corresponding quarter of the previous year, reflecting a 12.6 percent YoY increase. EBITDA margin improved to 11.63 percent from 11.43 percent, indicating a 20 basis point expansion.
Revenue and PAT figures, QoQ comparisons, management commentary, consensus estimates, and market reaction were not provided in the available information. The reported operating performance shows year-on-year improvement in EBITDA and margin for the quarter.
Unichem Laboratories Reports Consolidated Second Quarter Profit Recovery
ResultUNICHEMLAB4 Nov 2026
Unichem Laboratories reported consolidated second quarter net profit of Rs 22.20 crores, compared with a net loss of Rs 11.90 crores in the corresponding quarter of the previous year. This represents a year-on-year improvement of Rs 34.10 crores, or 286.6 percent, and marks a recovery to profitability.
Revenue from operations, EBITDA, operating margin, net margin, quarter-on-quarter comparison, and analyst consensus estimates were not provided in the available update. Accordingly, no assessment of revenue growth, EBITDA performance, margin movement, or earnings versus expectations has been included.
The result is favorable at the PAT level because the company moved from a consolidated loss to a consolidated profit. The earnings update relates to Unichem Laboratories Limited, a pharmaceutical company listed on NSE under the symbol UNICHEMLAB and on BSE under code 506690.
Unichem Laboratories Goa Facility USFDA Inspection Ends With Five Observations
Stock NewsUNICHEMLAB26 Sept 2026
Unichem Laboratories reported that a USFDA inspection of its formulation facility in Goa concluded with five observations related to procedural enhancements. The company is required to submit its response to the observations within 15 days. The available information does not specify any quantified financial impact, product recall, production disruption, supply interruption, or change in manufacturing capacity.
The observations are compliance-related and require corrective procedural measures. Their effect on earnings, regulatory status, and US market supplies will depend on the company’s response and any subsequent USFDA assessment. No stock price reaction on the inspection announcement date was provided.
Unichem Laboratories faces Rs 87.07 crore CGST penalty, plans to appeal
Stock NewsUNICHEMLAB19 Sept 2026
Unichem Laboratories has been hit with a Central Goods and Services Tax (CGST) demand and penalty amounting to Rs 87.07 crores. The order indicates that the tax authorities have raised a substantial claim against the company, which may relate to the interpretation or application of indirect tax provisions on its operations. Such a sizeable penalty exposes the company to potential cash outflows and could have implications for its near-term liquidity position if the demand is eventually upheld by the appellate authorities. However, the company has stated its intention to challenge and appeal the CGST order, suggesting that it disputes the basis or quantum of the tax demand. The appeals process under Indian tax law typically spans multiple stages, and final resolution can take time, during which the company may seek a stay or other relief on payment obligations.
From an earnings perspective, any eventual confirmation of the Rs 87.07 crores penalty could weigh on profitability in the impacted financial year, especially if the amount is required to be expensed or provided for in the accounts. For a mid-sized pharmaceutical company, this level of tax exposure is material and could influence investor perception of regulatory and compliance risks. Conversely, if the appeal results in a substantial reduction or cancellation of the demand, the adverse financial impact may be mitigated. The news is likely to draw attention in the market and could increase near-term volatility in the stock price of Unichem Laboratories as investors reassess tax-related contingencies and governance standards. At this stage, there is no explicit indication of any immediate change in the company’s core business operations, product portfolio, or ongoing projects due to this development, but management focus may be partly diverted towards managing the legal and regulatory process.
Unichem Lab reports higher Q1 EBITDA and margin improvement
ResultUNICHEMLAB11 Aug 2026
Unichem Lab reported Q1 EBITDA of Rs 69.60 crores versus Rs 22.50 crores a year earlier, reflecting a sharp year on year increase. EBITDA margin improved to 11% from 4.3% in the same period last year.
The update is limited to operating performance, and no revenue or PAT figures were provided in the context. No guidance, management commentary, or market reaction was included. The result points to materially better operating efficiency in the quarter compared with the corresponding period last year.
Unichem Lab reports higher Q1 revenue at Rs 630 crore
ResultUNICHEMLAB11 Aug 2026
Unichem Lab reported Q1 revenue of Rs 630.00 crores, up from Rs 530.00 crores in the same period last year, representing year on year growth of about 18.9%.
No EBITDA, PAT, margin, or quarter on quarter figures were provided in the context, so those metrics are not included. The update is a routine quarterly revenue disclosure for the company under the Equity earnings and corporate results category.
Unichem Lab reports Q1 consolidated net profit of Rs 41 crores
ResultUNICHEMLAB11 Aug 2026
Unichem Laboratories reported Q1 consolidated net profit of Rs 41.00 crores, compared with a loss of Rs 10.50 crores in the same quarter last year. The update provided does not include revenue, EBITDA, margins, or quarter-on-quarter figures, so those metrics cannot be assessed from the available information.
The result indicates a strong year-on-year turnaround in bottom-line performance for the pharmaceutical company. No management commentary, guidance, or market reaction was provided in the context, and there is no additional verified data here on the operating drivers behind the improvement.
Unichem Laboratories informs about disclosure
Stock NewsUNICHEMLAB12 Jun 2026
NULL
Unichem Lab - Quaterly Results
ResultUNICHEMLAB22 May 2026
NULL
Unichem Lab reports lower Q4 EBITDA and margin versus last year
ResultUNICHEMLAB22 May 2026
Unichem Laboratories reported Q4 EBITDA of Rs 34.90 crores, compared with Rs 83.70 crores in the same quarter last year. EBITDA margin for the quarter came in at 6.07%, versus 14.25% a year earlier. The update indicates a sharp year on year decline in operating profitability for the quarter.
The available information does not include revenue, PAT, or quarterly sequential comparison, so those figures are not stated. Based on the disclosed numbers alone, the result reflects weaker operating performance and lower margin realization in the reported quarter.
Unichem Lab reports lower Q4 profit and slightly softer revenue
ResultUNICHEMLAB22 May 2026
Unichem Laboratories reported Q4 consolidated net profit of Rs 11.00 crores, compared with Rs 53.00 crores in the same quarter last year, indicating a sharp decline in bottom-line performance.
Revenue for the quarter stood at Rs 580.00 crores versus Rs 590.00 crores a year ago, reflecting a marginal year-on-year decline. The update provided only revenue and net profit figures, and no additional details were disclosed here on EBITDA, margins, or management commentary.
For NSE/BSE market participants, the release points to weaker quarterly earnings on a year-on-year basis, with profit pressure more pronounced than the modest revenue change. As no consensus estimates, sequential comparison, or stock reaction were provided, the summary remains limited to the reported results.
Unichem Lab reports Profit after tax of Rs -15.39 Crores, in the March 2026 quarter
ResultUNICHEMLAB22 May 2026
NULL
Unichem Laboratories’ arm recalls 500-count bottles of Buspirone Hydrochloride Tablets
Stock NewsUNICHEMLAB13 Apr 2026
Unichem Pharmaceuticals (USA) has recalled the product after out-of-specification assay result identified at the 12-month long-term stability time point
Unichem Laboratories Voluntarily Recalls Buspirone Hydrochloride 5 Mg Tablets in US.
Stock NewsUNICHEMLAB13 Apr 2026
Unichem Laboratories has voluntarily recalled its Buspirone Hydrochloride 5 Mg Tablets in the United States. This action pertains to the company's pharmaceutical product distributed in the US market.
The recall is categorized under equity news for banking, corporate news, movers today, and stock alerts, with UNICHEMLAB as the affected symbol. Voluntary recalls typically address potential quality, safety, or efficacy concerns identified post-market, though specific reasons are not detailed in the announcement.
Such regulatory actions in key export markets like the US can impact revenue streams from international sales, potentially affecting overall earnings if the product represents significant volume. Unichem Laboratories, operating in the pharmaceuticals sector, may face costs related to recall logistics, remediation, and possible regulatory scrutiny from US FDA.
Unichem Laboratories informs about certificate
Stock NewsUNICHEMLAB7 Apr 2026
NULL
Unichem Laboratories informs about scrutinizers report
Stock NewsUNICHEMLAB30 Mar 2026
NULL
Unichem Laboratories informs about trading window closure
Stock NewsUNICHEMLAB24 Mar 2026
NULL
Unichem Laboratories informs about postal ballot notice
Stock NewsUNICHEMLAB25 Feb 2026
NULL
Unichem Lab - Quaterly Results
ResultUNICHEMLAB5 Feb 2026
NULL

